These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20343817)

  • 21. Laboratory diagnosis of congenital coagulation defects.
    Lowe GD; Forbes CD
    Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
    [No Abstract]   [Full Text] [Related]  

  • 22. Canine hemophilia; observations on the course, the clotting anomaly, and the effect of blood transfusions.
    GRAHAM JB; BUCKWALTER JA
    J Exp Med; 1949 Aug; 90(2):97-111. PubMed ID: 18136192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bridge anticoagulant; a hitherto unrecognized blood clotting inhibitor in haemophilic and Christmas-disease plasma; a simple method for its demonstration.
    NOUR-ELDIN F; WILKINSON JF
    Br J Haematol; 1958 Jan; 4(1):38-50. PubMed ID: 13499832
    [No Abstract]   [Full Text] [Related]  

  • 24. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 25. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
    HOAK JC; CONNOR WE; WARNER ED
    J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
    [No Abstract]   [Full Text] [Related]  

  • 26. Nature of the blood clotting mechanisms in hemophilia.
    JOHNSON SA; McCLAUGHRY RI; SEEGERS WH
    J Mich State Med Soc; 1955 Jul; 54(7):797-800. PubMed ID: 13243059
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical blood clotting patterns in hemophilia.
    SPAET TH; KINSELL B; BEHRING HM; AGGELER PM
    Stanford Med Bull; 1953 May; 11(2):118-23. PubMed ID: 13076908
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nature of the coagulation defect in hemophilia; studies on platelet-free plasmas.
    HARTMAN RC; CONLEY CL; LALLEY JS
    Am J Med; 1949 Apr; 6(4):507. PubMed ID: 18208241
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombelastographic observations on the characteristics of hemophilic, thrombocytopenic and heparinized blood.
    DE NICOLA P; MAZZETTI GM
    Blood; 1956 Jan; 11(1):71-80. PubMed ID: 13276486
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molecular-biology findings on various blood clotting factors].
    Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the behavior of thrombocytes in hemophiliacs and their female conductors].
    FONIO A
    Schweiz Med Wochenschr; 1959 Oct; 89():1026-8. PubMed ID: 13823801
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemophilia B; two familial case of blood disease due to deficiency of a new coagulation factor, Christmas factor].
    CRAMER R; MATTER M; LOELIGER A
    Helv Paediatr Acta; 1953 Jun; 8(3):185-201. PubMed ID: 13095871
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.
    Tokunaga N; Inoue C; Sakata T; Kagawa K; Abe M; Takamatsu N; Nakao T; Doi T
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):474-6. PubMed ID: 26523912
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research on the antithromboplastin factors in hemophilia. 1. The plasma antithromboplastin of Tocantins].
    CHEVALLIER P; FIEHRER A; BILSKI-PASQUIER G; SAMAMA M
    Sang; 1955; 26(4):362-76. PubMed ID: 13246570
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrastructural aspects of interactions of platelets with microcrystalline collagen.
    Zucker WH; Mason RG
    Am J Pathol; 1976 Jan; 82(1):129-42. PubMed ID: 1082242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.